• No se han encontrado resultados

Agenda productiva de investigación y desarrollo tecnológico para la cadena productiva de la tilapia

N/A
N/A
Protected

Academic year: 2020

Share "Agenda productiva de investigación y desarrollo tecnológico para la cadena productiva de la tilapia"

Copied!
95
0
0

Texto completo

Loading

Figure

Tabla 1.  Consumo  per cápita en libras de pescados más populares en Estados Unidos,  2000-2004
Tabla 2 .  Principales  países  exportadores  de  tilapia  referidos  en  la  base  Fish  Stat  Plus,  1995-2005   País  1.995  1.996  1.997  1.998  1.999  2.000  2.001  2.002  2.003  2.004  2.005  Taiwán  0  16.261  29.583  35.155  40.039  31.087  47.317
Tabla 3 . Importaciones de principales países importadores según información registrada  en la base FishStat Plus, 1995-2005
Tabla 4.  Producción piscícola nacional por departamentos, 2002 – 2007.
+7

Referencias

Documento similar

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

This section provides guidance with examples on encoding medicinal product packaging information, together with the relationship between Pack Size, Package Item (container)

Package Item (Container) Type : Vial (100000073563) Quantity Operator: equal to (100000000049) Package Item (Container) Quantity : 1 Material : Glass type I (200000003204)

If certification of devices under the MDR has not been finalised before expiry of the Directive’s certificate, and where the device does not present an unacceptable risk to health

In addition to the requirements set out in Chapter VII MDR, also other MDR requirements should apply to ‘legacy devices’, provided that those requirements

The notified body that issued the AIMDD or MDD certificate may confirm in writing (after having reviewed manufacturer’s description of the (proposed) change) that the

diabetes, chronic respiratory disease and cancer) targeted in the Global Action Plan on NCDs as well as other noncommunicable conditions of particular concern in the European

 Tejidos de origen humano o sus derivados que sean inviables o hayan sido transformados en inviables con una función accesoria..  Células de origen humano o sus derivados que